We studied the β-1,3-galactosyltransferase (GalT) and A-1,2-fucosyltansferase (FT) involved in the biosynthesis of type-1-chain carbohydrate antigens in human colon adenocarcinoma cell lines. We detected a GalT activity able to use GlcNAc as acceptor and found that lacto-N-biose I (Galβ1-3GlcNAc) is the only reaction product. Such β1,3GalT is kinetically similar to a pig trachea enzyme involved in mucin synthesis. The specific activity is high in cells that react strongly with anti-Lewis a and anti-Lewis b antibodies, and undetectable in a cell line that lacks antibody reaction. Reverse-transcriptase-mediated PCR analysis followed by DNA sequencing indicated that secretor-type A1,2FT is expressed in the cells, while the H type A1,2FT is not. The apparent K m values for donor and acceptor substrates determined for A1,2FT are similar to those of secretor-type A1,2FT and the specific activity measured correlates with Lewis b antigen expression on the cell surface. Moreover, some of the cell lines express Lewis y and H type 2 antigens, indicating that secretor type A1,2FT is responsible for their synthesis. Results suggest that biosynthesis of type-1-chain tumor-associated antigens in human colon carcinoma cells is operated by secretor-type A1,2FT, as reported in normal mucosa, and that β1,3GalT activity may play a relevant role in its control.Keywords : glycosyltransferase; carbohydrate antigen; colon carcinoma ; immunostaining.Association with tumor progression and malignancy has been reported for several carbohydrate antigens [1,2] and recent data suggest this is presumably due to their involvement in selectin-dependent tumor cell adhesion to the vascular endothelium [3,4]. Type-1-chain carbohydrate antigens such as SLe a (NeuAcA2-3Galβ1-3[FucA1-4]GlcNAc) and GlcNAc) are expressed in several cancers [1, 5Ϫ8]. Specific involvement of SLe a in selectin-dependent cell adhesion has been suggested [9, 10] and its stage-specific expression has been described in embryonic pancreas [11]. In the case of Le b, as well as in that of its type 2 chain counterpart Le y (FucA1-2Galβ1-4[FucA1-3]GlcNAc) [12,13], the molecular basis of their association with malignancy is still not fully elucidated.The biosynthesis of type-1-chain tumor markers depends on the activity of a galactosyltransferase (GalT) able to operate the Correspondence to